vimarsana.com
  1. Home
  2. Live Updates
  3. MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT : vimarsana.com

MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT

MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France ,Germany ,Florent Malard ,European Medicines Agency ,Trophic Communications ,Senior Pr Corporate Communications ,European Society For Blood ,Sorbonne University ,Microbiome Ecosystem ,Saint Antoine Hospital ,Overall Survival ,Orphan Drug Designation ,European Society ,Marrow Transplantation ,Maat Pharma ,Microbiome Ecosystem Therapies ,Euronext Paris ,Investor Relations ,Media Relations ,Communications Manager ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.